Group 1 - Longbai Group's subsidiary plans to introduce strategic investors and implement capital increase, with a total investment of 2 billion yuan, resulting in a 31.40% equity stake for the investors [1] - Upwind New Materials' embodied intelligent robot business is still in the product development stage and is not expected to positively impact the 2025 annual performance [2] - Kweichow Moutai's controlling shareholder has completed a share buyback plan, acquiring approximately 207.14 million shares for about 3 billion yuan, increasing their total stake to 56.63% [3] Group 2 - Xiamen Tungsten's subsidiary plans to acquire 100% equity of German Mimatic Tool Company for a base price of 10 million euros, with additional capital increase planned [4] - Longpan Technology's subsidiary will reduce production on some lithium iron phosphate production lines for maintenance, expecting a reduction of about 5,000 tons [5] - Wenkai Co. plans to invest 29 million yuan to establish a fund focused on strategic emerging industries [6] Group 3 - Limin Co.'s subsidiary has received a production license for "fluopyram" pesticide, which is expected to have a positive impact on future operations [7] - ST Huicheng received a cash donation of 30 million yuan from its restructuring investor to support its operations [8] - Baitong Energy's vice president plans to reduce holdings of up to 316,200 shares, representing 0.0686% of the total share capital [9] Group 4 - Wushang Group's shareholder did not execute a planned share reduction, retaining a 5.7% stake [10] - Zhangzidao's major shareholder plans to reduce holdings of up to 711,100 shares, representing 1% of the total share capital [11] - Meihua Bio plans to repurchase shares worth 35 million to 50 million yuan at a price not exceeding 15 yuan per share [12] Group 5 - Xiyang Co. plans to distribute a cash dividend of 1.10 yuan per 10 shares, totaling 181 million yuan, which is 10.37% of the net profit for the first three quarters of 2025 [13] - Weike Technology plans to distribute a cash dividend of 6 yuan per 10 shares, totaling approximately 75.15 million yuan [14] - Guoyuan Securities plans to transfer 24.33% of Anyuan Fund's equity for 813 million yuan [15] Group 6 - Three Gorges Tourism's subsidiary plans to purchase part of the property for the Three Gorges Cruise Center for 136 million yuan [16] - Wukuang Development plans to acquire equity in Wukuang Mining and Luzhong Mining, with stock suspension announced [17][18] - Sijia Technology plans to invest 275 million yuan to acquire 20% equity in Guangcai Xincheng [19] Group 7 - Changan Automobile plans to raise no more than 6 billion yuan through a private placement for new energy vehicle projects [20] - Shenjian Co. reported that its aerospace business revenue is relatively small, accounting for only 0.20% of total revenue [21] - Zhiyuan New Energy's controlling shareholder plans to reduce holdings of up to 1.53% of the company's shares [22] Group 8 - Beimo High-tech plans to raise no more than 1.97 billion yuan through a private placement for various projects [23] - Hongri Pharmaceutical's injectable thymosin has passed the consistency evaluation for generic drugs [24] - Ningbo Fangzheng plans to acquire 20% equity in Anhui Fangzheng for 63.8 million yuan [25] Group 9 - Spring Airlines signed a purchase agreement for 30 Airbus A320neo aircraft, with a total price not exceeding 4.128 billion USD [26][27] - Oulu Tong's controlling shareholder plans to reduce holdings of up to 1.91% of the company's shares [28] - Tongli Technology plans to invest 86.7 million yuan to increase capital in Zhuerkang Technology [29] Group 10 - Ganfeng Lithium received a notice of prosecution for suspected insider trading, but operations remain normal [30] - ST Dongyi completed its capital increase plan and will resume trading [31] - Tianpu Co. clarified that it has no plans to engage in artificial intelligence-related business [32] Group 11 - ST Meigu's restructuring plan has been completed, and it will apply to lift the delisting risk warning [33] - Unigroup Guowei is planning to acquire controlling or full equity of Ruineng Semiconductor, with stock suspension announced [34] - Shengtong Energy's stock has been suspended for investigation due to significant price fluctuations [35][36] Group 12 - ST Sansheng applied to lift the delisting risk warning after completing its restructuring plan [37] - Yuekang Pharmaceutical submitted an application for H-share listing on the Hong Kong Stock Exchange [38] - Miaokelando's controlling shareholder plans to increase holdings of 2.55 million to 5.10 million shares [39] Group 13 - SMIC plans to acquire 49% equity in SMIC North for 40.601 billion yuan, aiming to enhance asset quality and business synergy [40]

Core Viewpoint - The restructuring of *ST San Sheng has been completed, leading to a new board of directors and management team, marking a significant governance overhaul under the new controlling shareholder Hebei Jiheng Group [1][2][3] Group 1: Board Restructuring - The company held its 2025 second extraordinary general meeting on December 29, where the election of the sixth board of directors was approved, including both non-independent and independent directors [1] - The new board consists of four non-independent directors and three independent directors, all nominated by the new controlling shareholder, Hebei Jiheng Group, which effectively controls the majority of the board [2] Group 2: Management Appointments - The first meeting of the new board resulted in the election of Song Yingjian as chairman and legal representative, with Duan Weiwei as vice chairman [1] - Key management appointments include Huang Zhongqiang as general manager, Gao Xuying and Dong Yongting as deputy general managers, Liu Xuemei as financial director, Zhang Xiao as board secretary, and Xu Huaijun as head of the audit and supervision department [1] Group 3: Completion of Restructuring - On December 26, the company announced the completion of its restructuring plan, which involved introducing investors and adjusting equity to resolve its debt crisis and avoid bankruptcy [3] - The completion of the restructuring is expected to significantly improve the company's asset-liability structure and enhance its core competitiveness and profitability, aiming for sustainable development [3] - Following the restructuring, the company has applied to the Shenzhen Stock Exchange to lift the delisting risk warning that was triggered by the court's acceptance of its restructuring [3]

Group 1 - The company *ST San Sheng (002742)* has applied to the Shenzhen Stock Exchange to revoke the delisting risk warning due to its restructuring, but uncertainty remains regarding the approval [2] - The company has negative net assets and has reported losses for consecutive years, which means that even if the delisting risk warning is lifted, the stock will still face other risk warnings [2] - The restructuring plan has been completed, and relevant reports confirm its execution, eliminating the delisting risk warning related to the court's acceptance of the restructuring [2] Group 2 - The company operates primarily in the building materials and chemical industry, as well as pharmaceutical manufacturing [3] - For the first three quarters, the company reported total operating revenue of 737 million yuan, a year-on-year decrease of 25.24%, and a net loss attributable to shareholders of 178 million yuan, compared to a loss of 4 million yuan in the same period last year [3]

Core Viewpoint - *ST San Sheng (002742.SZ) held its first employee representative meeting on December 29, 2025, where Zhang Jian was elected as the employee representative director of the sixth board of directors [1] Group 1 - The employee representative meeting resulted in the election of Zhang Jian as a director [1] - Zhang Jian will join eight non-employee representative directors elected at the second extraordinary general meeting of shareholders in 2025 [1] - The term for the sixth board of directors will commence from the approval date of this employee representative meeting until the term of the sixth board expires [1]

资料显示，新任董事长宋英健现任冀衡集团董事、总经理，具备丰富的企业管理与产业运营经验，其执 掌*ST三圣，被市场视为冀衡集团深度整合优质资源、推动企业重生的重要信号。魏东、马胜义同为冀 衡集团核心高管，分别兼任集团旗下冀衡药业等子公司要职，有助于实现业务协同与资源赋能。段伟为 自2024年6月至今于深圳市高新投集团有限公司三圣股份风险化解专班任现场负责人，出任副董事长， 彰显了新管理层在化解历史遗留问题、稳定经营秩序方面的战略考量。 高管团队同步亮相，聘任黄中强为公司总经理，聘任高序英、董永廷为副总经理，聘任刘学梅为财务总 监(财务负责人)，聘任张潇为董事会秘书，聘任徐怀军为审计监察部负责人。其中，高序英为冀衡集团 监事、冀衡药业董事，董永廷此前为冀衡化学产业部主任，刘学梅为冀衡房地产公司财务负责人。 伴随治理结构的全面更新，*ST三圣同步发布公告称，公司重整计划已执行完毕，根据《深圳证券交易 所股票上市规则》相关规定，因法院裁定受理重整而触发的退市风险警示情形已消除。公司已向深交所 申请撤销因被法院裁定受理重整而触及的退市风险警示情形。(郑渝川) 随着重整计划的全面执行完毕，*ST三圣（002742）正式开 ...

Group 1 - The company *ST San Sheng has appointed new executives, including Huang Zhongqiang as General Manager and Liu Xuemai as Chief Financial Officer [1] - The revenue composition for *ST San Sheng in the first half of 2025 is as follows: 59.77% from pharmaceuticals, 39.94% from building materials, and 0.29% from other businesses [1] - As of the report date, *ST San Sheng has a market capitalization of 3.2 billion yuan [1] Group 2 - A new type of chip has been developed in China, which can support AI training and embodied intelligence, and is capable of mass production using mature processes of 28 nanometers and above [1]

证券代码：002742 证券简称：*ST 三圣 公告编号：2025-86 号 重庆三圣实业股份有限公司 关于聘任高级管理人员及其他相关人员的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 重庆三圣实业股份有限公司（以下简称"公司"）于 2025 年 12 月 29 日 召开第六届董事会第一次会议，审议通过了《关于聘任公司总经理的议案》、《关 于聘任公司其他高级管理人员的议案》、《关于聘任公司董事会秘书的议案》、《关 于聘任公司审计监察部负责人的议案》。现将相关情况公告如下： 电子邮箱：ir@cqssgf.com 备查文件： 重庆三圣实业股份有限公司第六届董事会第一次会议决议 特此公告。 根据《公司法》、《深圳证券交易所股票上市规则》及《公司章程》等相关规 定，公司董事会同意聘任黄中强先生为公司总经理；聘任高序英先生、董永廷先 生为公司副总经理；聘任刘学梅女士为公司财务总监，聘任张潇先生为公司董事 会秘书，聘任徐怀军先生为公司审计监察部负责人。黄中强先生、高序英先生、 董永廷先生、刘学梅女士、张潇先生任期三年，自董事会审议通过之日起至第六 届董事会任期届满 ...

证券代码：002742 证券简称：*ST 三圣 公告编号：2025-83 号 重庆三圣实业股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次会议无变更、取消、否决提案的情况； 2、本次会议不涉及变更前次股东大会决议。 一、会议召开情况 （一）会议名称：重庆三圣实业股份有限公司 2025 年第二次临时股东大会 （以下简称"本次大会"或"本次会议"） （二）召开时间： 1、现场会议召开时间：2025 年 12 月 29 日 14:30 2、网络投票时间：2025 年 12 月 29 日 （七）本次大会的召集、召开符合《公司法》、《上市公司股东会规则》以 及《公司章程》的规定，会议的表决程序和表决结果合法有效。 二、会议出席情况 其中：通过现场投票的股东 6 人，代表股份 192,551,332 股，占公司有表决 权股份总数的 28.1466%，通过网络投票的股东 107 人，代表股份 63,147,724 股， 占公司有表决权股份总数的 9.2307%；通过现场和网络投票的中小股东 110 人 ...

格隆汇12月29日丨*ST三圣(002742.SZ)公布，公司重整计划已执行完毕，根据《深圳证券交易所股票上 市规则》等相关规定，公司股票因被法院裁定受理重整而触及的退市风险警示情形已经消除，公司已向 深圳证券交易所（简称"深交所"）申请撤销因被法院裁定受理重整而触及的退市风险警示情形。公司已 于2025年4月26日在信息披露媒体发布2024年年度报告，经审计公司2024年度期末净资产为负值，根据 《上市规则》的相关规定，在深圳证券交易所同意公司撤销因重整而实施的退市风险警示后，公司股票 交易仍将继续被实施退市风险警示。若公司出现《上市规则》第9.3.12条规定的任一情形，公司股票将 被终止上市。因公司2022年、2023年及2024年连续三年扣除非经常性损益前后净利润均为负值，且最近 一年审计报告显示公司持续经营能力存在不确定性；主要银行账户被冻结；存在最近一年被出具否定意 见的内部控制审计报告，根据《上市规则》规定的情形，公司股票交易继续被叠加实施其他风险警示。 ...

证券代码：002742 证券简称：*ST 三圣 公告编号：2025-84 号 重庆三圣实业股份有限公司 关于选举职工代表董事的公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 根据《中华人民共和国公司法》《上市公司章程指引》《深圳证券交易所上 市公司自律监管指引第 1 号——主板上市公司规范运作》等法律、行政法规、规 范性文件及《公司章程》等有关规定，重庆三圣实业股份有限公司（以下简称"公 司"）于 2025 年 12 月 29 日召开 2025 年第一次职工代表大会，经全体与会职工 代表投票表决，同意选举张健先生为公司第六届董事会职工代表董事（简历附后）。 张健先生与公司 2025 年第二次临时股东大会选举产生的 8 名非职工代表董事共 同组成公司第六届董事会，任期自本次职工代表大会审议通过之日起至第六届董 事会任期届满之日止。 张健先生符合《公司法》有关董事任职的资格和条件。公司董事会中兼任公 司高级管理人员以及由职工代表担任的董事人数总计不超过公司董事总数的二 分之一。 特此公告 重庆三圣实业股份有限公司董事会 2025 年 12 月 29 日 职工 ...